This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention CenterBoston, USA

Amish Patel
SVP, Technical Activity Operations at Calidi Biotherapeutics


Dr. Patel has over 20+ years of global biopharma leadership experience, providing strategic guidance throughout the biologic product life cycle. Dr. Patel is responsible for critical oversight of Global Manufacturing, CMC, Quality, and Supply Chain teams to produce Clinical and Commercial therapies utilizing Calidi’s innovative allogenic cell-based delivery of oncolytic virus. Over the course of his career, he has led the development of over fifteen INDs, and biologic commercial product approvals. Dr Patel has been involved in taking viral, non viral, cell therapy, bacterial, small molecules from concept to clinic and commercialization. He frequently gives back to the scientific community by participating in NIH review panels, Technical Activity Committee at NIIMBL, Mentor at Biocom Life Science for future workforce development. Recently, Awarded Mentor of the year 2024, Honoree by San Diego Business Journal. Dr. Patel received Ph.D. in Engineering/Nanotechnology and MS in Chemical Engineering from Louisiana Tech University. He has Bachelors of Engineering in Chemical from Poona University, India.

Amish Patel's Network

Agenda Sessions

  • Chairperson's Remarks: Manufacturing Strategy

  • NIIMBL’s Progress in Advancing the Bioprocessing Field and Future Directions

  • Building Winning Teams: Essential Ingredients for Successful Advanced Therapy Collaborations

  • Building Winning Teams: Essential Ingredients for Successful Advanced Therapy Collaborations

  • Chairperson’s Opening Remarks: Cell Therapy Manufacturing

  • Adaptability of AI/ML for the BioPharma Industry

  • Overcoming Hurdles when distributing CGTs Across Multiple Regions and Markets